Compounds for the treatment of metabolic disorders

The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.

Saved in:
Bibliographic Details
Main Authors DUPREE TOM BANKSIA, JEEVARATNAM REVATHY PERPETUA, WITHALL DAVID MATTHEW, SWAIN SIMON ANDREW, STEWART ALAN JOHN WILLIAM, SCHOFIELD KAREN LESLEY, FRY PETER TIMOTHY, FYFE MATTHEW COLIN THOR, BARBA OSCAR, SMYTH DONALD, STONEHOUSE DAVID FRENCH, STAROSKE THOMAS, KRULLE THOMAS MARTIN
Format Patent
LanguageChinese
English
Published 28.03.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
Bibliography:Application Number: CN201080017147